Debut Plus

₹36.23

▼ -0.96 -2.58%

As of 23 Oct 2026 · delayed

NSE Listed

Vineet Laboratories Ltd. (VINEETLAB)

Volume: 1,53,945Avg Vol 1W: 1,50,400.6Avg Vol 1M: 1,33,468.2552W Range:₹27.96₹43.5
NSE BSE vineetlabs.co.in AI Report
Key Ratios
Checked 21h ago
Market Cap₹70 Cr
Current Price₹36.23
Previous Close₹37.19
High / Low (52w)₹43.5 / ₹27.96
Volume1,53,945
Avg Vol (1W)1,50,400.6
Avg Vol (1M)1,33,468.25
Stock P/E0
Book Value₹15.89
Dividend Yield—
ROE0%
ROA—
Revenue (TTM)₹77 Cr
Revenue Growth—
Profit Margin—
Total Debt₹4 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹-21.9
P/B1.92
Debt / Equity1.71
50 DMA₹37.18
200 DMA₹34.77
Day change-2.58%
Price Chart
₹36.23▼ 3.54% · 1Y
₹42₹299.2L
2025-10-27
2026-10-23

20-day avg volume: 1.3L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 100% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹24 Cr₹19 Cr₹18 Cr₹14 Cr₹7 Cr₹17 Cr₹16 Cr₹19 Cr
EBITDA₹-1 Cr₹-1 Cr₹-5 Cr₹-10 Cr₹0 Cr₹3 Cr₹2 Cr₹2 Cr
Net Profit₹-2 Cr₹-2 Cr₹-6 Cr₹-11 Cr₹-1 Cr₹0 Cr₹1 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹0 Cr₹244 Cr₹191 Cr₹212 Cr₹151 Cr₹77 Cr
EBITDA₹0 Cr₹0 Cr₹7 Cr₹11 Cr₹5 Cr₹5 Cr₹-17 Cr
Net Profit₹0 Cr₹0 Cr₹2 Cr₹7 Cr₹1 Cr₹1 Cr₹-20 Cr
EPS002.187.161.361.11-21.9
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹0 Cr₹0 Cr₹109 Cr₹133 Cr₹116 Cr₹117 Cr₹95 Cr
Total Liabilities₹0 Cr₹0 Cr₹82 Cr₹100 Cr₹82 Cr₹82 Cr₹80 Cr
Equity₹0 Cr₹0 Cr₹27 Cr₹33 Cr₹34 Cr₹35 Cr₹15 Cr
Total Debt———————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹27 Cr₹11 Cr₹-7 Cr₹-6 Cr₹12 Cr
Investing₹-8 Cr₹-4 Cr₹-7 Cr₹-2 Cr₹-3 Cr
Financing₹19 Cr₹12 Cr₹0 Cr₹8 Cr₹-8 Cr
Free Cash Flow₹27 Cr₹11 Cr₹-7 Cr₹-6 Cr₹12 Cr
Shareholding
Promoter 5.98% Institutions 0.24% Public 93.78%
About Vineet Laboratories Ltd.

Basic Materials · Chemicals

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.

vineetlabs.co.in ↗
Efficiency & Working Capital
ROCE6.8%
Interest Coverage-4.2
Dividend Payout—
Debtor Days64 d
Inventory Days243 d
Payable Days164 d
Cash Conversion Cycle144 d
Working Capital Days308 d
Shareholding Details

As of 2026-09-30

Promoter6%
FII0.2%
DII0%
Institutions0.2%
Public93.8%
Promoter Pledge0%
No. of Shareholders9,724
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Feb 2026Mar 2026Jun 2026Sept 2026
Promoters37.5%37.5%36.1%35.8%35.8%29.3%15.9%12.5%6%6%6%6%
FIIs0%0%0%0%0%0%0%0%0%0.4%0.5%0.2%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public62.5%62.5%63.9%64.2%64.2%70.7%84.1%87.5%94%93.7%93.5%93.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9,6389,52310,30010,05810,0259,9889,68210,00310,0429,9299,9019,724
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Arjun AggarwalPublic Shareholding9.8%18,80,177
Mangal Keshav Capital LimitedPublic Shareholding4.2%8,00,000
Galaxy Prime Private LimitedPublic Shareholding2.6%5,00,000
Gaddam Venkata RamanaShareholding of Promoter and Promoter Group2.5%4,71,600
Madhu NalajalaPublic Shareholding2.4%4,62,085
Rajesh PoddarPublic Shareholding2.2%4,13,256
Rajendra AgrawalPublic Shareholding1.6%3,02,087
Ajay AgrawalPublic Shareholding1.5%2,93,668
Surekha Naga Lakshmi PendelaPublic Shareholding1.5%2,89,161
Sujata Kumari JhaPublic Shareholding1.4%2,73,643
Jyoti AgarwalPublic Shareholding1.4%2,66,212
Suraj Wealth Management Private LimitedPublic Shareholding1.1%2,15,227
Charan Reddy PuliPublic Shareholding1.1%2,07,500
Rajeev MakkarPublic Shareholding1.1%2,02,268
Satyanarayana Raju Bhupathirajuin30273410069180Shareholding of Promoter and Promoter Group0.7%1,32,145
A Prabhakar RajuShareholding of Promoter and Promoter Group0.5%95,476
A Srinivasa RajuShareholding of Promoter and Promoter Group0.5%94,386
A Ranga RajuShareholding of Promoter and Promoter Group0.4%74,243
Alluri Anantha LaxmiShareholding of Promoter and Promoter Group0.3%65,641
Alluri MythiliShareholding of Promoter and Promoter Group0.3%54,795
Penmetsa Venkata Krishnam RajuShareholding of Promoter and Promoter Group0.3%47,988
P Kishore RajuShareholding of Promoter and Promoter Group0.3%48,812
Gaddam SrinivasaraoShareholding of Promoter and Promoter Group0.2%36,232
Gaddam Venkata RamaShareholding of Promoter and Promoter Group0.1%25,011
V Varaprasada Raoin30051319920588Shareholding of Promoter and Promoter Group0%1,000
Board of Directors
NameDesignationYear
Dilip V AcharekarChairman & Independent Directo2025
Bhupathiraju S RajuED / WTD / CFO / Promoter2025
Gaddam Venkata RamanaED / MD / Promoter2025
Alluri Ranga RajuNon Executive Director2025
Hari Priya YerukalapudiIndependent Non Exe. Director2025
Ramesh Kumar BandariCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacture of Drug Intermediates &₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹75 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1011119
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500017980
202500014143
202500003838
Insider / Designated-Person Trades

8 recent disclosure(s)

Alluri MaithiliDisposal · 20,000
Alluri Ranga RajuDisposal · 11,600
Pericharla Kishore RajuDisposal · 3,500
Alluri Anantha LaxmiDisposal · 10,000
Alluri Srinivasa RajuDisposal · 5,000
Gaddam Venkata RamanaDisposal · 61,070
Substantial Acquisitions (SAST)

1 disclosure(s)

Rights Issue02/02/2026 · 21,80,000
Company Information
Incorporated2016
ChairmanDilip V Acharekar
AuditorNSVR & Associates LLP
Investor Email[email protected]
🌐 www.vineetlabs.co.in ↗

📍 SyNo 11/A3 Saheb Nagar KurduVi, Chintal Kunta Eshwaramma LB Nr, Hyderabad, Telangana, 500074

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Vilas Transcore LimitedVilin Bio Med LimitedVimta Labs LimitedVinati Organics Ltd.Vintage Coffee N Bvrgs LimitedVindhya Telelinks Ltd.Vinny Overseas LimitedVinod Texworld LimitedRekvina Laboratories Ltd.Vinsys IT Services India Ltd.Vinyas Innovative Technologies Ltd.Vinyl Chemicals (I) Ltd.All “V” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search